Cargando…
Screening for Fatal Traumatic Brain Injuries in Cerebrospinal Fluid Using Blood-Validated CK and CK–MB Immunoassays
A single, specific, sensitive biochemical biomarker that can reliably diagnose a traumatic brain injury (TBI) has not yet been found, but combining different biomarkers would be the most promising approach in clinical and postmortem settings. In addition, identifying new biomarkers and developing la...
Autores principales: | Zwirner, Johann, Anders, Sven, Bohnert, Simone, Burkhardt, Ralph, Da Broi, Ugo, Hammer, Niels, Pohlers, Dirk, Tse, Rexson, Ondruschka, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301791/ https://www.ncbi.nlm.nih.gov/pubmed/34356685 http://dx.doi.org/10.3390/biom11071061 |
Ejemplares similares
-
Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid
por: Zwirner, Johann, et al.
Publicado: (2021) -
Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017) -
Survival-time dependent increase in neuronal IL-6 and astroglial GFAP expression in fatally injured human brain tissue
por: Trautz, Florian, et al.
Publicado: (2019) -
Forensic biomarkers of lethal traumatic brain injury
por: Zwirner, Johann, et al.
Publicado: (2022) -
Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
por: Li, Yan, et al.
Publicado: (2023)